Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer

Gynecologic Oncology

Volumn 123, Issue 2, 2011, Pages 241-247

  Mabuchi, Seiji ^a   Okazawa, Mika ^b   Isohashi, Fumiaki ^a   Matsuo, Koji ^c   Ohta, Yukinobu ^b   Suzuki, Osamu ^b   Yoshioka, Yasuo ^a   Enomoto, Takayuki ^a   Kamiura, Shoji ^b   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cervical cancer; Definitive radiotherapy; FIGO stage IIB; Radical hysterectomy; Survival

Indexed keywords

NEDAPLATIN;

ADJUVANT RADIOTHERAPY; ADULT; ANEMIA; ARTICLE; BLADDER DYSFUNCTION; BLADDER PERFORATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CYSTIC LYMPHANGIOMA; DEFINITIVE RADIOTHERAPY; DIARRHEA; ENTEROCOLITIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FRACTURE; HISTOPATHOLOGY; HUMAN; HYDRONEPHROSIS; INTERMETHOD COMPARISON; LYMPHEDEMA; MAJOR CLINICAL STUDY; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RADICAL HYSTERECTOMY; RECURRENCE RISK; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE PERFORATION; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 80054736592     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.07.009     Document Type: Article

References (26)

1. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, and P. Perego Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 1997 535 540
2. G.W. Morley, and J.C. Seski Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion) Am J Obstet Gynecol 126 1976 785 798
3. C.A. Perez, H.M. Camel, M.S. Kao, and M.A. Hederman Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report Gynecol Oncol 27 1987 129 140
4. M. Undurraga, P. Loubeyre, J.B. Dubuisson, D. Schneider, and P. Petignat Early-stage cervical cancer: is surgery better than radiotherapy? Expert Rev Anticancer Ther Mar 10 2010 451 460
5. P. Suprasert, J. Srisomboon, and T. Kasamatsu Radical hysterectomy for stage IIB cervical cancer: a review Int J Gynecol Cancer 15 2005 995 1001
6. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Cervical Cancer-v.1.2011. http://www.nccn.org/professionals/physician- gls/pdf/cervical.pdf.
7. J.L. Benedet, F. Odicino, P. Maisonneuve, U. Beller, W.T. Creasman, and A.P. Heintz Carcinoma of the cervix uteri Int J Gynaecol Obstet 83 Suppl. 1 2003 41 78
8. Annual report from Cancer Registry Committee of Japan Society of Obstetrics and Gynecology Acta Obstet Gynaecol Jpn 35 1983 737 752
9. T. Kasamatsu, T. Onda, M. Sawada, T. Kato, and S. Ikeda Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation Gynecol Oncol 114 2009 69 74
10. H. Yamashita, K. Okuma, K. Kawana, S. Nakagawa, K. Oda, and T. Yano Comparison between conventional surgery plus postoperative adjuvant radiotherapy and concurrent chemoradiation for FIGO stage IIB cervical carcinoma: a retrospective study Am J Clin Oncol 33 2010 583 586
11. M. Rotman, A. Sedlis, M.R. Piedmonte, B. Bundy, S.S. Lentz, and L.I. Muderspach A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study Int J Radiat Oncol Biol Phys 65 2006 169 176
12. A. Sedlis, B.N. Bundy, M.Z. Rotman, S.S. Lentz, L.I. Muderspach, and R.J. Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study Gynecol Oncol 73 1999 177 183
13. S. Mabuchi, K. Morishige, F. Isohashi, Y. Yoshioka, T. Takeda, and T. Yamamoto Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors Gynecol Oncol 115 2009 482 487
14. S. Mabuchi, M. Okazawa, F. Isohashi, Y. Ohta, S. Maruoka, and Y. Yoshioka Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases Gynecol Oncol 120 2011 94 100
15. T. Inoue, and K. Morita Long-term observation of patients treated by postoperative extended-field irradiation for nodal metastases from cervical carcinoma stages IB, IIA, and IIB Gynecol Oncol 58 1995 4 10
16. S. Mabuchi, H. Ugaki, F. Isohashi, Y. Yoshioka, K. Temma, and N. Yada-Hashimoto Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone Gynecol Obstet Invest 69 2010 224 232
17. S. Mabuchi, F. Isohashi, Y. Yoshioka, K. Temma, T. Takeda, and T. Yamamoto Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy Int J Gynecol Cancer 20 2010 834 840
18. M.J. Halaska, M. Novackova, I. Mala, M. Pluta, R. Chmel, and H. Stankusova A prospective study of postoperative lymphedema after surgery for cervical cancer Int J Gynecol Cancer 20 2010 900 990
19. K. Kashima, T. Yahata, K. Fujita, and K. Tanaka Analysis of the complications after radical hysterectomy for stage IB, IIA and IIB uterine cervical cancer patients J Obstet Gynaecol Res 36 2010 555 559
20. A. Huscher, M. Bignardi, E. Magri, E. Vitali, N. Pasinetti, and L. Costa Determinants of small bowel toxicity in postoperative pelvic irradiation for gynaecological malignancies Anticancer Res 29 2009 4821 4826
21. Y. Ohba, Y. Todo, N. Kobayashi, M. Kaneuchi, H. Watari, and M. Takeda Risk factors for lower-limb lymphedema after surgery for cervical cancer Int J Clin Oncol 16 2011 238 243
22. F.J. Montz, C.H. Holschneider, S. Solh, L.C. Schuricht, and B.J. Monk Small bowel obstruction following radical hysterectomy: risk factors, incidence, and operative findings Gynecol Oncol 53 1994 114 120
23. M.D. Hasselle, B.S. Rose, J.D. Kochanski, S.K. Nath, R. Bafana, and C.M. Yashar Clinical Outcomes of Intensity-Modulated Pelvic Radiation Therapy for Carcinoma of the Cervix Int J Radiat Oncol Biol Phys 80 2011 1436 1445
24. T. Kamura, N. Tsukamoto, N. Tsuruchi, T. Kaku, T. Saito, and N. To Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection - an analysis with mathematical statistics Int J Gynecol Cancer 3 1993 219 225
25. L.C. Horn, U. Fischer, G. Raptis, K. Bilek, and B. Hentschel Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer Gynecol Oncol 107 2007 310 315
26. M.J. Moore, B. O'Sullivan, and I.F. Tannock How expert physicians would wish to be treated if they had genitourinary cancer J Clin Oncol 6 1988 1736 1745